|  | Comment: The FDA is overcautious about consumer genomics testing Image: Sandy Huffaker/Bloomberg/Getty Evidence is emerging that consumer genetics testing does not cause distress or risky behaviour, say bioethicist and legal scholar Nita Farahany and medical geneticist Robert C. Green in a Comment piece in this week’s Nature. Farahany and Green describe several studies assessing how a total of more than 5,000 individuals who underwent consumer genomics testing responded to their own genetic information, noting that there was no clear evidence of harm and some evidence of benefit. Access the article online. Please note that this email refers to a Nature Comment piece, not a Nature research paper or article. Comment pieces are topical, authoritative Op-Eds pertaining to scientific research and its ramifications. | |
| |
| This offer is not available in Japan, Korea and mainland China (excluding Hong Kong and Taiwan). | | | |
No comments:
Post a Comment